John Bush Idoko | Cardiology | Research Excellence Award

Published on by Health Scientists

Health Scientists Awards

John Bush Idoko
Near East University, Cyprus

John Bush Idoko
Affiliation Near East University
Country Cyprus
Scopus ID 57200209705
Documents 55
Citations 481
h-index 10
Subject Area Cardiology
Event Health Scientists Awards

John Bush Idoko is a researcher affiliated with Near East University in Cyprus whose scholarly activities span medical and health sciences with notable engagement in cardiology-related research and interdisciplinary biomedical investigations. His publication portfolio demonstrates contributions to machine learning applications in health sciences, neurological signal processing, and clinical analytics. The researcher has established measurable academic visibility through indexed publications, citations, and collaborative scientific output documented in major international databases.[1]

Abstract

This academic article presents a structured overview of the scholarly profile and research contributions of John Bush Idoko of Near East University, Cyprus. The page evaluates the researcher’s publication activities, citation indicators, interdisciplinary collaborations, and contributions to health science and biomedical analytics. Particular attention is given to publications associated with neurological diagnostics, deep learning applications in medicine, and computational approaches to health-related signal analysis. The article further discusses the relevance of the researcher’s scientific portfolio within the context of the Health Scientists Awards and highlights the consistency of publication productivity and research visibility within indexed academic databases.[2]

Keywords

Cardiology, Biomedical Engineering, Machine Learning, EEG Analysis, Deep Learning, Health Sciences, Clinical Analytics, Medical Informatics, Computational Medicine, Scientific Impact

Introduction

Contemporary health sciences increasingly integrate computational technologies, biomedical analytics, and artificial intelligence methodologies to improve diagnostic accuracy and healthcare efficiency. Researchers working at the intersection of medical sciences and intelligent systems contribute significantly to the modernization of healthcare research infrastructure. John Bush Idoko’s scholarly activities align with these evolving academic trends through publications associated with neural network methodologies, biomedical signal processing, and clinical interpretation systems.[3]

The international research environment has increasingly recognized interdisciplinary scientific collaborations that combine computational modeling with clinical sciences. Academic researchers contributing to this area frequently engage in studies involving diagnostic systems, machine learning algorithms, and predictive analytics for medical applications. Publications attributed to John Bush Idoko indicate participation in these developing scientific domains with measurable scholarly visibility across indexed academic platforms.[1]

Research Profile

John Bush Idoko is affiliated with Near East University in Cyprus and has developed an academic profile characterized by interdisciplinary research contributions involving medical sciences, signal processing, and intelligent computational systems. According to indexed bibliographic records, the researcher has produced 55 documents with 481 citations and an h-index of 10, reflecting moderate and consistent scholarly engagement within internationally indexed literature.[1]

The researcher’s publication trajectory demonstrates collaborative engagement with scientists from multiple institutions and disciplinary backgrounds. Several studies involve neural networks, convolutional deep learning systems, biomedical image interpretation, and clinical decision-support methodologies. Such interdisciplinary research profiles are increasingly important in modern health science ecosystems where computational methods assist in healthcare diagnostics and patient management strategies.[4]

Research Contributions

The research contributions associated with John Bush Idoko include investigations into biomedical signal analysis, epileptic EEG identification systems, and deep learning approaches for medical pattern recognition. These contributions reflect ongoing scientific interest in leveraging computational intelligence to improve diagnostic precision and clinical interpretation methodologies.[2]

One area of scholarly contribution involves convolutional neural network applications for EEG signal classification. Research in this area supports the development of automated neurological analysis systems capable of assisting healthcare practitioners in diagnostic processes. Such studies contribute to broader efforts within biomedical engineering and clinical informatics aimed at improving healthcare efficiency and analytical reliability.[3]

Additional contributions include studies related to sign language translation using deep neural networks and interdisciplinary artificial intelligence frameworks applied to health communication technologies. These works collectively illustrate the researcher’s participation in computational approaches that support healthcare accessibility, diagnostic automation, and biomedical data interpretation.[4]

Publications

  • Abiyev, R., Arslan, M., Idoko, J. B., Sekeroglu, B., & Ilhan, A. “Identification of epileptic EEG signals using convolutional neural networks.” Applied Sciences, 2020.
    https://doi.org/10.3390/app10124089
  • Abiyev, R. H., Arslan, M., & Idoko, J. B. “Sign language translation using deep convolutional neural networks.” KSII Transactions on Internet and Information Systems, 2020.
    https://doi.org/10.3837/tiis.2020.02.018
  • Research publications involving biomedical data analytics, machine learning applications, and intelligent healthcare systems indexed within Scopus and Google Scholar databases.[1]

Research Impact

The measurable research impact associated with John Bush Idoko is reflected through citation activity, interdisciplinary collaborations, and publication visibility across recognized indexing platforms. Citation metrics indicate that the researcher’s publications have contributed to ongoing academic discussions within biomedical engineering, computational medicine, and health informatics.[1]

The integration of deep learning methodologies into biomedical diagnostics represents an active area of international scientific development. Contributions related to EEG analysis and medical classification systems have relevance to modern healthcare technologies and emerging intelligent diagnostic infrastructures. Such research may contribute to future clinical applications, data interpretation systems, and computational healthcare solutions.[2]

Award Suitability

The scholarly profile of John Bush Idoko demonstrates characteristics commonly associated with academic recognition programs in health sciences, including interdisciplinary collaboration, indexed publication output, citation visibility, and engagement with emerging biomedical technologies. The integration of artificial intelligence methodologies into health science investigations aligns with evolving priorities within international healthcare research communities.[4]

The Health Scientists Awards program recognizes researchers whose academic contributions support innovation, scientific advancement, and interdisciplinary development in healthcare-related fields. Based on available bibliographic indicators and publication themes, the researcher’s profile demonstrates relevance to these academic evaluation criteria.[5]

Conclusion

John Bush Idoko’s academic profile reflects ongoing contributions to interdisciplinary health science research involving machine learning, biomedical analytics, and intelligent diagnostic systems. Indexed publications, citation metrics, and collaborative research activities collectively indicate sustained engagement with contemporary computational healthcare methodologies. The researcher’s portfolio demonstrates relevance within emerging scientific areas that integrate biomedical sciences and artificial intelligence technologies. Such contributions support broader international efforts aimed at improving healthcare diagnostics, analytical efficiency, and digital health innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: John Bush Idoko, Author ID 57200209705. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57200209705
  2. Abiyev, R., Arslan, M., Idoko, J. B., Sekeroglu, B., & Ilhan, A. (2020). Identification of epileptic EEG signals using convolutional neural networks. Applied Sciences.
    https://doi.org/10.3390/app10124089
  3. Google Scholar. (n.d.). John Bush Idoko citation profile and indexed publications.
    https://scholar.google.com/citations?user=eVqc6HkAAAAJ&hl=en&oi=ao
  4. Sekeroglu, B., Abiyev, R., Ilhan, A., Arslan, M., & Idoko, J. B. “Systematic literature review on machine learning and student performance prediction: Critical gaps and possible remedies.” Applied Sciences, 11(22), 10907. https://doi.org/10.3390/app112210907
  5. Health Scientists Awards. (n.d.). Official award information and evaluation categories.
    https://healthscientists.org/

Gauthami Pulivendala | Translational Research | Young Researcher Award

Published on by Health Scientists

Dr. Gauthami Pulivendala | Translational Research | Young Researcher Award

Postdoc Associate | University of Miami | United States

Dr. Gauthami Pulivendala is a researcher at Sylvester Comprehensive Cancer Center, specializing in cancer biology, fibrosis, and molecular signaling pathways. Her work focuses on understanding mechanisms such as the ChREBPα-mediated regulation of hepatic stellate cell activation and its role in liver fibrosis, contributing to advancements in translational oncology. With 11 publications, 318 citations, and an h-index of 9, she demonstrates strong research impact and scientific productivity. Collaborating with an extensive network of co-authors, her research reflects interdisciplinary engagement across cancer biology and metabolic disease domains. Her contributions hold significant societal value by advancing knowledge in fibrosis and tumor microenvironment interactions, supporting the development of targeted therapies, and improving clinical strategies for cancer and liver-related diseases, thereby contributing to global health innovation and patient care outcomes.

Citation Metrics (Scopus)

318
240
160
80
0

Citations

318

Documents

11

h-index

9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications


Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

– Drug Delivery and Translational Research, 2020 | Citations: 62

Hui Saan Tham | Translational Research | Research Excellence Award

Published on by Health Scientists

Dr. Hui Saan Tham | Translational Research | Research Excellence Award

Director | Han Neuro Acupuncture & Herbal Specialist | Malaysia

Dr. Hui Saan Tham is the Chief Physician at Han Neuro Acupuncture and Herbal Specialists, specializing in translational research that integrates acupuncture, herbal medicine, and advanced medical technologies. Their recent publication on an EfficientNet-based deep learning system for ultrasound assessment of neck disorders reflects a pioneering approach to combining artificial intelligence with clinical diagnostics. Working collaboratively with multidisciplinary teams, they contribute to the development of innovative, evidence-based healthcare solutions. Although at an emerging stage in terms of publication count and citation metrics, their work demonstrates strong potential for impact in integrative and precision medicine. Their contributions hold significant societal value by promoting accessible, non-invasive therapeutic strategies and enhancing diagnostic accuracy, particularly in neuromuscular conditions, thereby supporting improved patient outcomes and advancing global healthcare innovation.

View Google Scholar Profile

Featured Publication

Raphael Duval | Pharmacology | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Raphael Duval | Pharmacology | Research Excellence Award

Dean | Université de Lorraine | France

Raphaël E. Duval is a senior academic leader and clinical microbiologist serving as Professor and Dean of the Faculty of Pharmacy at Université de Lorraine, France. His expertise spans infectiology, virology, cellular biology, and pharmaceutical sciences, with a strong focus on the discovery and development of innovative anti-infective and anticancer therapeutic agents. His research is widely disseminated through international peer-reviewed journals, scholarly book chapters, patents, and invited scientific communications, reflecting significant academic influence and citation impact. He actively collaborates with multidisciplinary teams across academia and industry at national and international levels. Recognized through prestigious scientific awards and fellowships, his work contributes to advancing therapeutic innovation, strengthening infectious disease management, and addressing major public health challenges with meaningful societal and clinical impact. He has 4909 citations from 98 documents with an h-index of 34.

Citation Metrics (Scopus)

4909
3500
2000
1000
0

Citations

4,909

Documents

98

h-index

34

Citations

Documents

h-index

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile

Featured Publications

Saeed Aghebat Bekheir | Translational Research | Research Excellence Award

Published on by Health Scientists

Dr. Saeed Aghebat Bekheir | Mental Health | Research Excellence Award

PhD Candidate in Toxicology | Tehran University of Medical Sciences | Iran

Dr. Saeed Aghebat Bekheir is a dedicated researcher and PhD candidate in Toxicology at Tehran University of Medical Sciences, working under the mentorship of Prof. Abdollahi. His research focuses on mitochondrial toxicology, cardiotoxicity, and mechanistic modeling of toxin-induced bioenergetic failure, with a particular emphasis on developing therapeutic strategies for aluminum phosphide–induced mitochondrial dysfunction. Dr. Aghebat Bekheir has demonstrated expertise in a wide range of experimental approaches, including in vivo animal studies, cellular and molecular assays, and in vitro toxicological models, integrating mechanistic toxicology with translational research to address acute mitochondrial injury and cardiotoxicity. His scholarly contributions are reflected in several peer-reviewed publications in high-impact journals, and he actively serves as a reviewer for multiple journals in toxicology and biomedical sciences, highlighting his commitment to advancing scientific rigor and dissemination. Collaboratively, he engages in research partnerships within the toxicology and mitochondrial research community, fostering interdisciplinary approaches to environmental and translational toxicology challenges. His work contributes to a deeper understanding of oxidative stress, bioenergetic disturbances, and cardiotoxic mechanisms, with broader implications for public health and therapeutic innovation. Beyond his laboratory and scholarly pursuits, Dr. Aghebat Bekheir’s research emphasizes societal relevance by addressing environmental toxicants and their impacts on human health, providing foundational knowledge for developing interventions to mitigate toxicity-related diseases. Through his professional memberships, editorial activities, and collaborative initiatives, he actively contributes to shaping the global toxicology landscape, promoting evidence-based strategies, and inspiring emerging researchers in the field. His ongoing research underscores a commitment to integrating scientific excellence with practical solutions for human health, reflecting both scholarly distinction and societal impact. He has 23 citations from 5 documents with an h-index of 3.

Profiles: Google Scholar | Scopus

Featured Publications

1. Ghanati, K., Jahanbakhsh, M., Shakoori, A., Aghebat-Bekheir, S., … (2024). The association between polycystic ovary syndrome and environmental pollutants based on animal and human study; a systematic review.

2. Ghanati, K., Eghbaljoo, H., Akbari, N., Mazaheri, Y., Aghebat-Bekheir, S., … (2023). Determination of melamine contamination in milk with various packaging: A risk assessment study.

3. Aghebat-Bekheir, S., Abdollahi, M. (2024). Discovering the most impactful treatments for aluminum phosphide cardiotoxicity gleaned from systematic review of animal studies.

4. Reihani, A., Marboutian, F., Aghebat-Bekheir, S., Reyhani, A., Akhgari, M. (2024). Diagnostic aspects of paraquat in the forensic toxicology: A systematic review.

5. Aghebat-Bekheir, S., Hekmatirad, S., Asar, N., Abdollahi, M. (n.d.). Aluminum phosphide as a model for exploring acute mitochondrial disorders.

Maryam Tehranipour | Pharmacology | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Maryam Tehranipour | Pharmacology | Best Researcher Award

Animal Physiology | Islamic Azad University | Iran

Dr. Maryam Tehranipour is an accomplished Associate Professor in the Department of Biology at the Islamic Azad University, Mashhad, Iran, recognized for her distinguished contributions to the fields of diabetes, metabolic disorders, neurobiology, oxidative stress, and cancer biology. Holding a Ph.D. in Animal Physiology, she has built a dynamic academic and research career integrating cellular physiology, pharmacology, and molecular mechanisms of disease. Her extensive publication record spans a broad spectrum of biomedical investigations, including neuroprotective strategies, natural product pharmacology, nanomedicine, and experimental models of diabetes and neurodegeneration. Dr. Tehranipour’s pioneering studies have elucidated the roles of oxidative damage, angiogenesis, and neuronal regeneration in disease progression and therapeutic recovery, particularly highlighting the potential of bioactive compounds and nanocarrier systems in drug design and targeted therapy. Her collaborative work has advanced understanding of diabetic complications, nerve injury repair, and cancer cell modulation through natural and synthetic agents. Beyond her prolific research output, she has played a significant role in mentoring undergraduate, graduate, and doctoral students, fostering scientific rigor and innovation in physiological research. Her scholarly influence is reflected through her indexed publications, contributions to interdisciplinary research networks, and global collaborations that link physiology, biochemistry, and nanotechnology for translational health impact. Dr. Tehranipour’s scientific endeavors emphasize the integration of experimental biology with clinical relevance, aiming to bridge laboratory discoveries with therapeutic applications. Through her ongoing research, she continues to contribute meaningfully to global biomedical science, particularly in developing sustainable and biologically safe therapeutic interventions addressing chronic and degenerative diseases that pose major public health challenges. She has 238 citations from 53 documents with an h-index of 9.

Profile: Scopus 

Featured Publications

1. The Umbelliprenin-CTAB cellulose nanocrystal delivery system prevents hyperglycemia in diabetic rats by activating the insulin receptor IR/PDK1 pathway. (2025). Scientific Reports. Open access.

2. The effects of N-butanol and ethyl acetate fractions of Ferula asafoetida hydroalcoholic extract on the expression of VEGF and FGF genes in the chorioallantoic membrane of chick embryos. (2025). Journal of Veterinary Research.Open access.

3. Bimetallic-based colorimetric aptasensor for the quantitative analysis of ampicillin using catalytic activity of ZrFe metal–organic framework and terminal deoxynucleotidyl transferase-assisted signal amplification. (2025). Bionanoscience. Open access.

4. The effect of Ziziphora clinopodioides hydroalcoholic extract on the neuronal density and histopathology of the hippocampal area CA2 in streptozotocin-induced Alzheimer’s model in male rats. (2025). Journal of Chemical Health Risks. Open access.

5. A novel alpha-terpineol-loaded niosome formulation coated with hyaluronic acid and evaluation of its anticancer properties in vitro. (2025). Journal of Molecular Liquids. Open access.

Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Published on by Health Scientists

Dr. Sipping Kemegne Marius Tresor | Pharmacology | Best Researcher Award

Research scholar | Slovak Academy of Sciences | Slovakia

Dr. Sipping Kemegne Marius Tresor is a biochemist and postdoctoral research fellow whose expertise spans immunopharmacology, cancer biology, inflammatory diseases, and phytomedicine, with a focus on natural bioactive compounds and their translational therapeutic applications. Trained at leading institutions across Africa and Europe, he has developed a strong multidisciplinary foundation integrating molecular biology, pharmacology, biotechnology, and clinical research principles to advance innovation in precision therapeutics. His research has pioneered the exploration and characterization of polysaccharide-rich bioactive fractions from medicinal fungi, particularly Ganoderma species, elucidating their antioxidant, anti-inflammatory, and anti-metastatic potentials and offering promising chemopreventive and therapeutic leads for cancer and immune-mediated disorders. His scientific contributions include peer-reviewed publications in internationally indexed journals and authorship of a scholarly book, demonstrating sustained commitment to advancing biomedical knowledge and global research excellence. Dr. Sipping’s work has been strengthened through impactful collaborations across Africa, Europe, and Asia with prominent scientists and international research groups, fostering interdisciplinary partnerships and capacity building in natural product research and immunotherapeutics. His ongoing investigations focus on isolating novel polysaccharides and developing nanotechnology-enabled drug delivery systems to enhance therapeutic efficacy against chronic inflammatory conditions, such as rheumatoid arthritis, bridging traditional bioresources with cutting-edge biomedical strategies. Beyond laboratory research, he is a certified clinical research professional committed to strengthening translational pathways from preclinical discovery to potential clinical application. His membership in distinguished scientific bodies reflects his dedication to contributing to the global research community. Driven by the vision to harness bioresources and advanced biotechnology for improved public health, Dr. Sipping aims to deliver innovative, accessible, and safe therapeutic options addressing cancer, autoimmune, and infectious diseases, thereby contributing to scientific progress and societal well-being. He has 81 citations from 9 documents with an h-index of 5.

Profiles:  Scopus | ORCID

Featured Publications

1. Sipping, M., Thakur, D., Singh, B., Njamen, D., & Mukherjee, S. (2025). Polysaccharide extract of Ganoderma resinaceum restricts breast cancer progression in vitro by intervening in epithelial–mesenchymal transition and cancer stemness. Revista Brasileira de Farmacognosia.

2. Sipping, M., Sathish Kumar, T., & Kamdem, N. (2025). Scientific investigation on antibacterial, antioxidant, cytotoxic effects and TLC bioautography of Terminalia schimperiania stem bark extracts. Journal of Complementary and Integrative Medicine.

3. Kamga Silihe, K., Defo Mbou, W., Ngo Pambe, J. C., Kenmogne, L. V., Fotso Maptouom, L., Kemegne Sipping, M. T., Zingue, S., & Njamen, D. (2023). Comparative anticancer effects of Annona muricata Linn (Annonaceae) leaves and fruits on DMBA-induced breast cancer in female rats. BMC Complementary Medicine and Therapies.

4. Nana Tchoupang, E., Yadji, V., Wangbara, J. B., Kemegne Sipping, M. T., Zingue, S., Njamen, D., & Mutalik, S. (2022). In vitro and in vivo antiproliferative actions of Solanum gilo Raddi (Solanaceae) fruit extract on breast tissues. Advances in Pharmacological and Pharmaceutical Sciences.

5. Kamga Silihe, K., Zingue, S., Kemegne Sipping, M. T., Busuioc Cazanevscaia, A., Dediu Botezatu, A. V., Njamen, D., & Dinica, R. M. (2022). The antioxidant potential of Ficus umbellata Vahl (Moraceae) that accelerates in vitro and in vivo anti-inflammatory protective effects. Applied Sciences.

Syeda Nadia Ahmad | Maternal Health | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Syeda Nadia Ahmad | Maternal Health | Best Researcher Award 

Assistant Professor | University of Chakwal | Pakistan

Dr. Syeda Nadia Ahmad, Ph.D is a distinguished academic and researcher whose professional journey reflects a sustained commitment to advancing the frontiers of biochemistry, molecular biology, and biomedical sciences. As Chairperson and accomplished faculty member, she has demonstrated exceptional leadership in fostering interdisciplinary collaboration and academic excellence within the life sciences. Her scholarly expertise spans biochemical pathways, molecular therapeutics, and metabolic research, with her work contributing significantly to understanding disease mechanisms and identifying innovative molecular targets for therapeutic development. Dr. Ahmad’s extensive portfolio of peer-reviewed publications in high-impact international journals underscores her scientific rigor and thought leadership, while her citations reflect the global recognition and influence of her research contributions. She has actively collaborated with national and international institutions, promoting translational research that bridges fundamental science with clinical and societal applications. Through her mentorship, Dr. Ahmad has nurtured the next generation of scientists, emphasizing ethical research practices, innovation, and scientific integrity. Her professional endeavors extend beyond academia through participation in conferences, editorial boards, and scientific networks that encourage global dialogue on biomedical advancement and public health innovation. Committed to societal betterment, Dr. Ahmad’s research initiatives align with sustainable health outcomes, targeting complex diseases and improving diagnostic and therapeutic strategies. Her visionary approach integrates scientific inquiry with community well-being, reflecting a balance between research excellence and social responsibility. Widely respected for her intellectual depth, organizational leadership, and dedication to knowledge dissemination, Dr. Syeda Nadia Ahmad continues to make a lasting impact on science, education, and society, embodying the ideals of academic integrity, collaborative progress, and transformative biomedical innovation. She has 71 citations from 39 documents with an h-index of 4.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Ahmad, S. N. (2024, May 23–25). A study on CCl₄-induced pathologies in male mouse testes and the investigation of the healing potential of four medicinal plant fruit extracts. Presented at the 3rd International Veterinary Biochemistry and Clinical Biochemistry Congress (VetBio2024), Van Yüzüncü Yıl University, Faculty of Veterinary Medicine, Department of Biochemistry.

2. Ahmad, S. N. (2024, May 15–16). The ameliorating effects of virgin olive oil in adrenal gland of mice exposed to lambda-cyhalothrin and cypermethrin. Presented at the 1st International Conference on Emerging Trends in Artificial Intelligence and Cyber Security (ICEAC-2024), Khawaja Fareed UEIT RYK.

3. Ahmad, S. N., Ishaq, T., Kanwal, M. A., Inayat, I., Abdullah, U., & Ahmad, K. R. (2024, May 13). Ameliorations of Olea ferruginea fruit pulp extract in CCl₄-induced testicular pathology in mice. Journal of Bioresource Management.

4. Ahmad, S. N. (2024, May 23–25). A study on CCl₄-induced pathologies in male mouse testes and the investigation of the healing potential of four medicinal plant fruit extracts. Presented at the 3rd International Veterinary Biochemistry and Clinical Biochemistry Congress (VetBio2024), Van Yüzüncü Yıl University, Faculty of Veterinary Medicine, Department of Biochemistry.

5. Younis, A., Hussain, I., Ahmad, S. N., Shah, A., Inayat, I., Kanwal, M. A., Suleman, S., Kamran, M. A., Matloob, S., & Ahmad, K. R. (2024, April 26). Validation of Bos taurus SNPs for milk productivity of Sahiwal breed (Bos indicus), Pakistan. Animals.

Dr. Syeda Nadia Ahmad’s pioneering research integrates molecular science with translational medicine, driving innovations that bridge laboratory discoveries to real-world health solutions. Her work advances biomedical knowledge, fosters sustainable therapeutic development, and contributes to global health equity through impactful scientific collaboration and societal engagement.

Siyu Chen | Pharmacology | Best Researcher Award

Published on by Health Scientists

 Prof. Siyu Chen | Pharmacology | Best Researcher Award

Professor | China Pharmaceutical University | China

Dr. Chen Siyu currently serves as the Deputy Director of the Department of Biochemistry at the School of Life Sciences and Technology, China Pharmaceutical University, where he is also a Professor, Doctoral Supervisor, and Chief Young Scientist of the National Key Research and Development Program. He obtained his academic training in biochemistry and molecular biology, cultivating a strong foundation in metabolic and biochemical sciences. Dr. Chen’s research primarily focuses on Target Discovery and Intervention Strategies for Metabolic Diseases, aiming to elucidate molecular mechanisms and identify novel therapeutic targets for metabolic regulation. He has published extensively as first or corresponding author in leading international journals such as Advanced Science, Nature Communications, and Gut Microbes, with his work widely cited by peers. His innovative research has led to the granting of national patents and multiple ongoing patent applications. Dr. Chen has successfully led major research projects under national and provincial funding programs, including the National Key R&D Program for Young Scientists, the National Natural Science Foundation for Young Scientists, and the Jiangsu Province Excellent Youth Fund. Recognized for his scholarly excellence, he received the Outstanding Doctoral Dissertation Award of Jiangsu Province. In addition to his research, Dr. Chen contributes actively to the academic community as a Young Member of the Metabolism Committee of the Chinese Society of Biochemistry, Director of the Jiangsu Society of Developmental Biology, and Editorial Board Member of Journal of China Pharmaceutical University and Progress in Biochemistry and Biophysics. He also serves as a Guest Editor for Frontiers in Endocrinology and a regular reviewer for leading journals including Journal of Hepatology and ACS Nano. He has 1616 citations from 60 documents with an h-index of 24.

Profiles: Scopus | ORCID

Featured Publications

1. Photosensitive biomimetic nanomedicine-mediated recombination of adipose microenvironments for antiobesity therapy. (2025). Advanced Materials.

2. Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity. (2025). Bioengineering and Translational Medicine.

3. Blue light-driven cell cycle arrest in thyroid cancer via Retinal-OPN3 complex. (2024). Cell Communication and Signaling.

4. Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. (2024). EMBO Molecular Medicine.

5. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer. (2024). Phytomedicine.

Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Assistant Professor | Shahid Beheshti University of Medical Sciences | Iran

Dr. Milad Rahimzadegan is an Assistant Professor at the Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, and serves as R&D Manager in multiple pharmaceutical companies. He earned his PhD in Pharmacy-Toxicology and Pharmacology from Tehran University of Medical Sciences, followed by an M.Sc. in Medical Toxicology from Tarbiat Modares University, and a B.A. in Plant Medicine from the University of Tehran. Recently, he completed a post-doctoral fellowship focused on Artificial Intelligence in Neuroscience at the Functional Neurosurgery Research Center. Dr. Rahimzadegan’s research spans neuropharmacology, neurotoxicology, regenerative medicine, and advanced drug delivery systems, with particular emphasis on stem cell differentiation, conductive scaffolds for spinal cord injury, and nano-biosensing for cardiovascular and neurodegenerative diseases. He has authored numerous high-impact publications in journals including Stem Cell Reviews and Reports, International Journal of Biological Macromolecules, Materials Science & Engineering C, and Carbohydrate Polymers, and has contributed to multiple books on pharmacology, regenerative medicine, and neurosurgery. His work has been recognized with awards such as the Top Academic Secretary of USERN Iran, Young Scientific Award at Shahid Beheshti University, and membership in Iran’s National Elites Foundation. In addition to his research contributions, he serves as a reviewer and editorial board member for journals including Interventional Pain Medicine and Neuromodulation and International Clinical Neuroscience Journal, reflecting his commitment to advancing scientific knowledge and fostering innovation in neuroscience, pharmacology, and translational medicine. He has 326 citations from 26 documents with an h-index of 11.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Rahimzadegan, M., & Soodi, M. (2018). Comparison of memory impairment and oxidative stress following single or repeated doses administration of scopolamine in rat hippocampus.

2. Asl, S. K., & Rahimzadegan, M. (2022). The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches.

3. Malek-Khatabi, A., Razavi, M. S., Abdollahi, A., & Rahimzadeghan, M., et al. (2023). Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery.

4. Asl, S. K., Rahimzadegan, M., & Asl, A. K. (2024). Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.

5. Asl, S. K., Rahimzadegan, M., & Ostadrahimi, R. (2024). The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction.